Herpes simplex virus vaccine in recurrent herpetic ocular infection

Cornea

Volumn 18, Issue 1, 1999, Pages 47-51

  Pivetti Pezzi, Paola ^a,b   Accorinti, Massimo ^a   Colabelli Gisoldi, Rossella Anna Maria ^a   Pirraglia, Maria Pia ^a   Sirianni, Maria Caterina ^b  

^a Serv Spec Immunovirologia Oculare   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Herpes simplex; Keratitis; Keratouveitis; Vaccine

Indexed keywords

ACICLOVIR; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HERPES SIMPLEX VACCINE; INACTIVATED VACCINE; LUPIDON; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEAT SHOCK; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HUMAN; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; RELAPSE; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE SUBPOPULATION; UVEITIS;

EID: 0032900296     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199901000-00008     Document Type: Article

References (27)

1. Liesegang TJ, Melton JL III, Daly PJ, et al. Epidemiology of ocular herpes simplex: incidence in Rochester, Minn. 1950 through 1982. Arch Ophthalmol 1989;107:1155-9.
2. Dawson CR, Togni B. Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv Ophthalmol 1976;21:121-35.
3. Cook SD. Herpes simplex virus in the eye. Br J Ophthalmol 1992; 76:365-6.
4. Arffa RC. Diseases of the cornea. St Louis: Mosby Year Book, 1991:238-65.
5. Nesburn AB. Immunological aspects of ocular herpes simplex disease. In: Suran A, Gery I, Nussenblatt RB, eds. Immunology of the eye, workshop III. London: IRL Press, 1981:21-42.
6. Easty DL, Carter C, Funk A. Systemic immunity in herpetic keratitis. Br J Ophthalmol 1981;65:82-5.
7. Klein RJ. Initiation and maintenance of latent herpes simplex virus infections: the paradox of perpetual immobility and continuous movement. Rev Infect Dis 1985;7:21-30.
8. Hyndiuk RA, Glasser DB. Herpes simplex keratitis. In: Tabbara KF, Hyndiuk RA, eds. Infections of the eye. 2nd ed. Boston: Little, Brown, 1996:361-85.
9. Colin J. Frequence de l'herpes oculaire, ses circostances d'apparition, ses particularites epidemiologiques. In: Pouliquen Y, Colin J, eds. L'Herpes Oculaire Bull Soc Ophthalmol France: Rapport Annuel. Marseille: Imprimarie Lamy, 1983:9-17.
10. Parrish CM, O'Day DM. Herpes simplex keratitis. In: Tasman W, Jaeger EA, eds. Duane's clinical ophthalmology, vol. 4. Philadelphia: Lippincott, 1995:1-29.
11. Pavan-Langston D. Malattie virali della cornea e della superficie oculare. In: Albert DM, Jakobiec FA, eds. Principi e pratica di oftalmologia. Roma: Verduci Editore, 1995:120-40.
12. Schuster JJ, Kaufman HE, Nesburn AB. Statistical analysis of the rate of recurrence of herpes virus ocular epithelial disease. Am J Ophthalmol 1981;91:328-31.
13. Tiradritti L, Mastrolorenzo A, Zuccati G, Panconesi E. Studio preliminare sull'effetto clinico ed immunologico di un vaccino antierpetico in un gruppo di soggetti affetti da herpes simplex facciale e genitale recidivante. Int J Drug Ther 1988;3:195-205.
14. Della Morte M, Colucci G. Impiego di metodiche di ibridizzazione e di amplificazione genica nella caratterizzazione di un nuovo antierpetico a base di HSV inattivato contenente le glicoproteine gB e gD. Acta Toxicol Ther 1992;13:50-9.
15. Pivetti-Pezzi P, De Liso P, Tamburi S, et al. Thymic factor therapy for herpetic keratitis. Ann Ophthalmol 1985;17:327-31.
16. Kaufman ME, Centifanto-Fitzgerald YM, Varnell ED. Herpes simplex keratitis. Ophthalmology 1983;90:700-6.
17. Missotten L. Immunology and herpetic keratitis. Eye 1994;8:12-21.
18. Pepose JS. Herpes simplex keratitis: role of viral infection versus immune response. Surv Ophthalmol 1991;35:345-52.
19. Bloomfield SE, Lopez C. Herpes infection in the immunosuppressed host. Ophthalmology 1980;87:1226-9.
20. Simon AL, Pavan-Langston D. Long term oral acyclovir therapy: effect on recurrent infectious herpes simplex keratitis in patients with and without grafts. Ophthalmology 1996;103:1399-405.
21. Asbell PA. Discussion of long term oral acyclovir therapy: effect on recurrent infectious herpes simplex keratitis in patients with and without grafts. Ophthalmology 1996;103:1404-5.
22. Blatt AN, Laycock KA, Brady RH, Traynor P, Krogstad DJ, Pepose JS. Prophylactic acyclovir effectively reduces herpes simplex type 1 reactivation after exposure of latently infected mice to ultraviolet B. Invest Ophthalmol Vis Sci 1993;34:3459-65.
23. The Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. Arch Ophthalmol 1997;115:703-12.
24. Bleidl D, Occella C, Schiazza L, Germogli R, Bozzo Costa E, Rampini E. Trattamento dell'herpes labialis e dell'herpes genitalis mediante immunostimolazione specifica. Acta Toxicol Ther 1987; 8:13-33.
25. Mastrolorenzo A, Tiradritti L, Salimbeni L, Zuccati G. Multicentre clinical trial with herpes simplex virus vaccine in recurrent herpes infection. Int J STD AIDS 1995;6:413-35.
26. Accorinti M, Colabelli-Gisoldi RAM, Pirraglia MP. Impiego di un vaccino antierpetico, costituito da virus dell'herpes simplex inattivati al calore, nella prevenzione delle infezioni oculari recidivanti da HSV. Boll Ocul 1996;75:1-2.
27. Salvetat ML. Impiego di un vaccino antierpetico, costituito da virus dell'herpes simplex di tipo 1 inattivati al calore, nella prevenzione delle cheratiti dendritiche e stromali recidivanti da HSV. Boll Ocul 1996;75:51-4.